trending Market Intelligence /marketintelligence/en/news-insights/trending/roqrwyuwdflihokjx4wv4a2 content esgSubNav
In This List

Aileron Therapeutics appoints chairman

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook


Aileron Therapeutics appoints chairman

Aileron Therapeutics, Inc. appointed Jeffrey Bailey as chairman of its board of directors.

Bailey serves as CEO and director of privately held device maker IlluminOss Medical, Inc.

He is also a director at Madison Vaccines, Inc.

Bailey replaces Scott Kapnick as chairman of the Cambridge, Mass.-based biotechnology company. Kapnick will remain on the company's board.

In addition, Aileron said Brian Gallagher Jr. resigned from the company's board.